[1] 中华人民共和国商务部. 国家发展改革委、外交部、商务部联合发布《推动共建丝绸之路经济带和21世纪海上丝绸之路的愿景与行动》[EB/OL].(2015-03-31)[2024-07-18]. http://www.mofcom.gov.cn/article/ae/ai/201503/20150300928878.shtml.
[2] WHO Collaborating Centre for Drug Statistics Methodology. ATC Index with DDDs [EB/OL].(2024-01-26)[2024-07-18]. https://www.whocc.no/atc_ddd_index_and_guidelines/atc_ddd_index/.
[3] GIBBS S. Skin disease and socioeconomic conditions in rural Africa: Tanzania[J]. Int J Dermatol, 1996, 35(9):633-639. doi:  10.1111/j.1365-4362.1996.tb03687.x
[4] World Health Organization. Noncommunicable diseases country profiles [EB/OL].(2018-09-24)[2024-07-18]. https://www.who.int/teams/noncommunicable-diseases/surveillance/data/profiles-ncd.
[5] 袁进, 刘贺萍, 许百虹, 等. 基于国内外指南评价某院含抗高血压药物的处方联用的合理性[J]. 中国药房, 2018, 29(15):2114-2118.
[6] WORLD BANK GROUP . Data [DB/OL].(2024-07)[2024-07-18]. https://data.worldbank.org.cn/.
[7] ANYANGWE S C, MTONGA C. Inequities in the global health workforce: the greatest impediment to health in sub-Saharan Africa[J]. Int J Environ Res Public Health, 2007, 4(2):93-100. doi:  10.3390/ijerph2007040002
[8] OGILVIE L, MILL J E, ASTLE B, et al. The exodus of health professionals from sub-Saharan Africa: balancing human rights and societal needs in the twenty-first century[J]. Nurs Inq, 2007, 14(2):114-124. doi:  10.1111/j.1440-1800.2007.00358.x
[9] DRUETZ T. Integrated primary health care in low- and middle-income countries: a double challenge[J]. BMC Med Ethics, 2018, 19(Suppl 1):48.
[10] World Health Organization. Public Financing for Health in Africa: from Abuja to the SDGs [EB/OL].(2016-08-26)[2024-07-18]. https://www.afro.who.int/publications/public-financing-health-africa-abuja-sdgs.
[11] BIGDELI M, JACOBS B, TOMSON G, et al. Access to medicines from a health system perspective[J]. Health Policy Plan, 2013, 28(7):692-704. doi:  10.1093/heapol/czs108
[12] NWAKA S, ILUNGA T B, SANTOS DA SILVA J, et al. Developing ANDI: a novel approach to health product R&D in Africa[J]. PLoS Med, 2010, 7(6):e1000293. doi:  10.1371/journal.pmed.1000293
[13] BRIGHT B, BABALOLA C P, SAM-AGUDU N A, et al. COVID-19 preparedness: capacity to manufacture vaccines, therapeutics and diagnostics in sub-Saharan Africa[J]. Global Health, 2021, 17(1):24. doi:  10.1186/s12992-021-00668-6
[14] McKinsey. Should sub-Saharan Africa make its own drugs? [EB/OL].(2019-10-1)[2024-07-18]. https://www.mckinsey.com/industries/public-sector/our-insights/should-sub-saharan-africa-make-its-own-drugs.
[15] AHEN F, SALO-AHEN O M H. Governing pharmaceutical innovations in Africa: Inclusive models for accelerating access to quality medicines[J]. Cogent Med, 2018, 5(1):1500196. doi:  10.1080/2331205X.2018.1500196
[16] World Health Organization. 1 in 10 medical products in developing countries is substandard or falsified [EB/OL].(2017-11-28)[2024-07-18]. https://www.who.int/news/item/28-11-2017-1-in-10-medical-products-in-developing-countries-is-substandard-or-falsified.
[17] NIELSEN I Q. Understanding the eating habits of the south African population [EB/OL]. (2021-5-17)[2024-07-18]. https://unlv-p-001-delivery.stylelabs.cloud/api/public/content/plate-of-the-nation-media-report-17-may-21.
[18] Ipsos. The changing food habits & attitudes of Egyptian consumers during the pandemic [EB/OL].(2020-12)[2024-07-18]. https://www.ipsos.com/sites/default/files/ct/news/documents/2020-12/food_trends_2020_-_egypt.pdf.
[19] World Health Organization. Malaria cases deaths [DB/OL]. (2023-11-30)[2024-07-18]. https://www.who.int/data/gho/data/themes/topics/topic-details/GHO/malaria-cases-deaths.
[20] ENDO N, YAMANA T, ELTAHIR E A B. Impact of climate change on malaria in Africa: a combined modelling and observational study[J]. Lancet, 2017, 389:S7. doi:  10.1016/S0140-6736(17)31119-4
[21] World Health Organization. eEML - Model List of Essential Medicines [DB/OL].(2023-7-26)[2024-12-05]. https://list.essentialmeds.org/.